highly significantP < 0.0001
The use of the thiazolidinedione (pioglitazone) was more in outpatients in comparison to that in inpatients, and this difference was highly significant ( P < 0.0001; χ 2 = 29.25).
The use of the thiazolidinedione (pioglitazone) was more in outpatients in comparison to that in inpatients, and this difference was highly significant ( P < 0.0001; χ 2 = 29.25).